Topic

Aetna (CVS Health)

A collection of 1351 issues

If Evkeeza Isn't Approved by Aetna CVS Health in Ohio: Formulary Alternatives & Exception Paths

Answer Box: If Aetna CVS Health denies Evkeeza (evinacumab-dgnb) for homozygous familial hypercholesterolemia (HoFH) in Ohio, you have two main paths: try formulary alternatives like Repatha (evolocumab) or Juxtapid (lomitapide), or appeal for a formulary exception. Aetna prefers PCSK9 inhibitors as first-line specialty therapy, requiring documented failure of maximally tolerated
5 min read

Get Koselugo (Selumetinib) Covered by Aetna CVS Health in New York: Complete Guide to Prior Authorization and Appeals

Answer Box: Quick Path to Approval Koselugo (selumetinib) requires prior authorization from Aetna CVS Health for pediatric patients ≥2 years with NF1 and symptomatic, inoperable plexiform neurofibromas. Your prescriber submits the PA with baseline LVEF (echocardiogram) and ophthalmologic evaluation results. Standard decisions take 30-45 days; expedited reviews complete within 72
5 min read

How to Get Rezlidhia (olutasidenib) Covered by Aetna (CVS Health) in Pennsylvania: Complete Appeals Guide with Forms and Timelines

Answer Box: Getting Rezlidhia (olutasidenib) Covered by Aetna (CVS Health) in Pennsylvania Fastest path to approval: Submit prior authorization through CVS Caremark or Aetna provider portal with IDH1 mutation test results, AML diagnosis confirmation, and documented failure of preferred alternatives. If denied, request peer-to-peer review within 180 days, then file
6 min read

Myths vs. Facts: Getting Cresemba (Isavuconazole) Covered by Aetna (CVS Health) in Illinois - Complete Appeals Guide

Answer Box: Getting Cresemba Covered by Aetna in Illinois Cresemba (isavuconazole) requires prior authorization from Aetna (CVS Health) in Illinois. You'll need documented invasive aspergillosis or mucormycosis, evidence of voriconazole failure/intolerance for aspergillosis cases, and typically an infectious disease specialist consultation. If denied, Illinois provides strong appeal
6 min read

The Requirements Checklist to Get Zolgensma (onasemnogene abeparvovec) Covered by Aetna (CVS Health) in Michigan

Answer Box: Getting Zolgensma Covered by Aetna (CVS Health) in Michigan Aetna requires prior authorization for Zolgensma (onasemnogene abeparvovec) via CVS Specialty Pharmacy. Key requirements: age under 24 months, bi-allelic SMN1 mutations, anti-AAV9 antibody titer ≤1:50, and treatment at a certified gene therapy center. Submit the Zolgensma Medication Precertification
6 min read

How to Get Vimizim (elosulfase alfa) Covered by Aetna (CVS Health) in California: Complete Prior Authorization and Appeals Guide

Getting Vimizim (elosulfase alfa) covered by Aetna (CVS Health) in California requires prior authorization with confirmed MPS IVA diagnosis, specialist prescription, and baseline functional assessments. Submit documentation via Aetna's provider portal or call 1-888-632-3862 for PA forms. If denied, file an internal appeal within 180 days, then request
5 min read

How to Get Hemgenix (etranacogene dezaparvovec) Covered by Aetna CVS Health in Virginia: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Hemgenix Covered by Aetna CVS Health in Virginia Hemgenix (etranacogene dezaparvovec) requires prior authorization from Aetna CVS Health. Adults with severe hemophilia B (≤2% Factor IX) on prophylaxis or with serious bleeding history can qualify. Submit complete documentation including Factor IX levels, inhibitor tests, bleeding history, and
7 min read